01657nas a2200205 4500000000100000008004100001260001600042100001600058700001600074700001500090700001500105700001500120700001300135700001100148245012400159856007600283300001100359520106700370022001401437 2025 d bElsevier BV1 aBockarie MJ1 ade Souza DK1 aAnsumana R1 aLadzekpo D1 aRamaiah KD1 aKarutu C1 aLee SS00aThe changing funding landscape for infectious disease research and control: implications for resource-limited countries uhttps://www.ijidonline.com/action/showPdf?pii=S1201-9712%2825%2900091-8 a1078683 a
We now live in an interconnected world where global health has become a critical concern for governments, international organizations, civil society, and individuals. Many emerging and re-emerging infectious disease threats, efforts to manage them, must be addressed collaboratively. In recent years, the pressures on overseas aid budgets of higher income countries like United Kingdom (UK) and United States (US) have impacted support for infectious disease research and control. As disease agents do not respect borders, promoting international health security should be the key focus of overseas aid, encompassing initiatives to combat infectious diseases like COVID-19, Ebola, mpox, malaria and neglected tropical diseases (NTDs). The fight against infectious diseases can be achieved through direct partnerships with affected countries and via multilateral organisations like World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), Africa CDC and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund).
a1201-9712